Khan, Fawad A. https://orcid.org/0000-0003-0486-5004
Malik, Alaa
Nelson, Evan
Fahimdanesh, Kian
Kaur, Karmveer
Elison, Jasmine
Sayed, Mohamed
Article History
Received: 24 June 2025
Accepted: 5 August 2025
First Online: 30 September 2025
Declarations
:
: Ethics approval – This case report was approved by Ochsner Neuroscience Research Review Committee.
: Written informed consent for publication, including the use of clinical details and clinical images, was obtained from the patient discussed in the manuscript.
: Fawad A. Khan reported receiving institutional research support from Biohaven, Teva, Marinus, Lundbeck, Supernus, Neurona, and UCB; advisory fees from Eisai, Neurelis, Marinus, Epitel, SK Life Science, AbbVie, Pfizer; honorarium for speaker engagements from Amgen, UCB, SK Life Science, Lundbeck, Abbvie, Lilly USA, Pfizer. He serves on the Louisiana State Medical Advisory Board in a non-paid position. In non-compensated roles, he is a board member of the Deccan Alumni Association of North America. Alaa Malik, Evan Nelson, Kian Fahimdanesh, Karmveer Kaur, Jasmine Elison, Mohamed Sayed report no conflicts of interest.